ZUM VERHALTEN DER IMMUNGLOBULINE BEI SEPTISCHEN HARNLEITERVERSCHLUSSSTEINEN. = COMPORTEMENT DES IMMUNOGLOBULINES DANS LES LITHIASES URETERALES OBSTRUCTIVES SEPTIQUESTUNN U; BRANDSTATER P.1976; THERAPIEWOCHE; DTSCH.; DA. 1976; VOL. 26; NO 26; PP. 4381-4384 (2P.); BIBL. 11 REF.Article

ZUM VERHALTEN DER IMMUNGLOBULINE BEI SEPTISCHEN HARNLEITERVERSCHLUSSSTEINEN = COMPORTEMENT DES IMMUNOGLOBULINES DANS LES LITHIASES URETERALES DESTRUCTIVES SEPTIQUESTUNN U; BRANDSTATER P.1976; THERAPIEWOCHE; DTSCH.; DA. 1976; VOL. 26; NO 26; PP. 4381-4384 (2P.); BIBL. 11 REF.Article

DAS EXTRAKORPORALE ULTRASCHALLBILD VON NIERENTUMOREN = L'ASPECT ECHOGRAPHIQUE EXTRACORPOREL DES TUMEURS RENALESTUNN U; THIEME H; SENGE T et al.1978; Z. UROL. NEPHROL.; DDR; DA. 1978; VOL. 71; NO 12; PP. 911-918; ABS. RUS/ENG; BIBL. 13 REF.Article

VERHALTEN DER SERUMIMMUNGLOBULINE IGA, IGM UND IGG NACH OPERATIVEN EINGRIFFEN UNTER ANTIBIOTIKABEHANDLUNG = TAUX DES IMMUNOGLOBULINES SERIQUES IGA, IGM ET IGG APRES INTERVENTIONS CHIRURGICALES SOUS ANTIBIOTHERAPIETUNN U; SENGE T; OTTEN E et al.1978; THERAPIEWOCHE; DEU; DA. 1978; VOL. 28; NO 47; PP. 9177-9189; (7 P.); BIBL. 20 REF.Article

LIPOID A-ANTIKOERPERTITER NACH URETEROSIGMOIDOSTOMIE = TAUX D'ANTICORPS CONTRE LE LIPOIDE A APRES URETEROSIGMOIDOSTOMIETUNN U; SENGE T; GALANOS C et al.1979; UROLOGE, A; DEU; DA. 1979; VOL. 18; NO 6; PP. 332-334; ABS. ENG; BIBL. 11 REF.Article

DIE BEHANDLUNG INFIZIERTER WEICHTEILWUNDEN IM BEREICH DES HARNTRAKTES MIT GENTAMYCIN-PMMA-KETTEN. = TRAITEMENT DES PLACES DES TISSUS MOUS DE L'APPAREIL URINAIRE PAR DES CHAINES DE GENTAMICINE. PMMASENGE T; TUNN U; AMMARI B et al.1978; UROLOGE, A; DTSCH.; DA. 1978; VOL. 17; NO 1; PP. 52-53; ABS. ANGL.; BIBL. 8 REF.Article

Intermittent endocrine therapy of prostate cancerTUNN, U. W.European urology. 1996, Vol 30, pp 22-25, issn 0302-2838, SUP1Conference Paper

EFFECTS OF CYPROTERONE ACETATE ON EXPERIMENTALLY INDUCED CANINE PROSTATIC HYPERPLASIA: A MORPHOLOGICAL AND HISTOCHEMICAL STUDYTUNN U; SENGE T; SCHENCK B et al.1980; UROL. INTERNATION.; CHE; DA. 1980; VOL. 35; NO 2; PP. 125-140; BIBL. 42 REF.Article

TESTOSTERONKONZENTRATION IN SERUM NACH SUBKAPSULAERER ORCHIEKTOMIE = CONCENTRATION SERIQUE DE TESTOSTERONE APRES ORCHIDECTOMIE SOUSCAPSULAIRESENGE T; HUELSHOFF T; TUNN U et al.1978; UROLOGE, A; DEU; DA. 1978; VOL. 17; NO 6; PP. 382-384; ABS. ENG; BIBL. 23 REF.Article

Advanced prostate cancer treatment guidelines: European perspectiveTUNN, U. W.BJU international. Supplement (Print). 2004, Vol 94, Num 3, issn 1465-5101, p. 6Conference Paper

Assessment and management of high-risk patientsTUNN, U. W.BJU international. Supplement (Print). 2004, Vol 94, Num 3, pp 11-13, issn 1465-5101, 3 p.Conference Paper

Intermittent androgen blockade in prostate cancer : Rationale and clinical expérienceWOLFF, J. M; TUNN, U. W.European urology. 2000, Vol 38, Num 4, pp 365-371, issn 0302-2838Conference Paper

Inhibiteurs de l'aromatase dans le traitement médical de l'hypertrophie prostatique bénigne = Drug therapy of benign prostatic hypertrophy by aromatase inhibitorTUNN, U. W; GOLDSCHMIDT, A. J. W.Journal d'urologie. 1993, Vol 99, Num 6, issn 0248-0018, p. 307Conference Paper

Endokrinologische Faktoren für die Entstehung der benignen Prostatahyperplasie = Facteurs endocriniens du développement de l'hyperplasie prostatique bénigne = Endocrinological factors in the development of benign prostatic hyperplasiaSCHWEIKERT, H.-U; NEUMANN, F; TUNN, U. W et al.Der Urologe. Ausgabe A. 1989, Vol 28, Num 6, pp 317-320, issn 0340-2592Article

ROLE OF THE PITUITARY GLAND IN EXPERIMENTAL HORMONAL INDUCTION AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA IN THE DOGELETREBY MF; FRIEDREICH E; HASAN SH et al.1979; CELL TISSUE RES.; DEU; DA. 1979; VOL. 204; NO 3; PP. 367-378; BIBL. 23 REF.Article

Prostatakarzinom: Stadieneinteilung durch transrektale Prostatasonographie und Computertomographie mit histopathologischer Korrelation = Tumeur de la prostate. Classification par échographie transprostatique et scanner avec corrélations anatomopathologique = Prostatic carcinoma. Staging with transrectal prostatic sonography and CT with histopathological correlationCORDES, M; TUNN, U. W; NEIDL, K et al.RöFo. Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 1987, Vol 146, Num 4, pp 412-414, issn 0340-1618Article

Transdifferentiation of distal but not proximal tubular epithelial cells from human kidney in cultureBAER, P. C; TUNN, U. W; NUNEZ, G et al.Experimental nephrology. 1999, Vol 7, Num 4, pp 306-313, issn 1018-7782Article

Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operationGINGELL, J. C; KNÖNAGEL, H; KURTH, K. H et al.The Journal of urology. 1995, Vol 154, Num 2, pp 399-401, issn 0022-5347, 1Article

The significance of serum levels of insulin-like growth factor in patients with prostate cancerKUREK, R; TUNN, U. W; ECKART, O et al.BJU international (Papier). 2000, Vol 85, Num 1, pp 125-129, issn 1464-4096Article

Endogenous pro-inflammatory cytokines in children and adolescents during chemotherapy-induced neutropeniaBANNING, U; MAUZ-KÖRHOLZ, C; MUHAMMAD, Q et al.Pediatric hematology and oncology. 2002, Vol 19, Num 8, pp 561-568, issn 0888-0018, 8 p.Article

Comparison of the effects of high dose estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer : an interim analysis of EORTC-GU group study NO. 30865NEWLING, D. W. W; FOSSA, S; TUNN, U et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 971-975, issn 0960-0760, 5 p.Conference Paper

Management of locally advanced prostate cancer: A European consensusBOCCON-GIBOD, L; BERTACCINI, A; BONO, A. V et al.International journal of clinical practice (Esher). 2003, Vol 57, Num 3, pp 187-194, issn 1368-5031, 8 p.Article

Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer : the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)NEWLING, D. W. W; FOSSA, S. D; TUNN, U. W et al.The Journal of urology. 1993, Vol 150, Num 6, pp 1840-1844, issn 0022-5347Article

Adjuvant chemotherapy for superficial transitional cell bladder carcinoma : Long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection aloneKURTH, K; TUNN, U; AY, R et al.The Journal of urology. 1997, Vol 158, Num 2, pp 378-384, issn 0022-5347Article

Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitorsHABENICHT, U.-F; TUNN, U. W; SENGE, T et al.Journal of steroid biochemistry and molecular biology. 1993, Vol 44, Num 4-6, pp 557-563, issn 0960-0760Conference Paper